These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8644929)

  • 1. [Functional magnetic resonance imaging (MRI) of hepatic ischemia in the rabbit. Contribution of a particulated contrast agent (AMI-25)].
    Canet E; Roger T; Chambon C; Delabre C; Baldy C; Revel D
    Anat Histol Embryol; 1996 Mar; 25(1):23-9. PubMed ID: 8644929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superparamagnetic iron oxide particles and positive enhancement for myocardial perfusion studies assessed by subsecond T1-weighted MRI.
    Canet E; Revel D; Forrat R; Baldy-Porcher C; de Lorgeril M; Sebbag L; Vallee JP; Didier D; Amiel M
    Magn Reson Imaging; 1993; 11(8):1139-45. PubMed ID: 8271900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).
    Saini S; Edelman RR; Sharma P; Li W; Mayo-Smith W; Slater GJ; Eisenberg PJ; Hahn PF
    AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic modeling of phagocytic activity of the liver using superparamagnetic iron oxide nanoparticles in dynamic MR imaging.
    Na JB; Suh JS; Huh YM; Kim SJ; Kim SH; Cha SH; Lee SH
    Yonsei Med J; 2003 Jun; 44(3):429-37. PubMed ID: 12833580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
    Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C
    Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superparamagnetic iron oxide for liver imaging. Comparison among three different preparations.
    Bach-Gansmo T; Fahlvik AK; Ericsson A; Hemmingsson A
    Invest Radiol; 1994 Mar; 29(3):339-44. PubMed ID: 8175309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
    Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
    Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Superparamagnetic iron particles. The clinical results in the MR diagnosis of liver metastases].
    Ham B; Reichel M; Vogl T; Taupitz M; Wolf KJ
    Rofo; 1994 Jan; 160(1):52-8. PubMed ID: 8305693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide.
    Mori K; Yoshioka H; Itai Y; Okamoto Y; Mori H; Takahashi N; Saida Y
    AJR Am J Roentgenol; 2000 Dec; 175(6):1659-64. PubMed ID: 11090400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in hepatic uptake and distribution of organ-specific superparamagnetic MRI contrast media: clinical findings and classification according to pathogenesis.
    Macarini L; Marini S; Murrone M; Ettorre GC
    Radiol Med; 2004; 108(1-2):92-106. PubMed ID: 15269693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a blood-pool contrast agent for MR-guided vascular procedures: feasibility of ultrasmall superparamagnetic iron oxide particles.
    Wacker FK; Wendt M; Ebert W; Hillenbrandt C; Wolf KJ; Lewin JS
    Acad Radiol; 2002 Nov; 9(11):1251-4. PubMed ID: 12449357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPIO-enhanced 2D-TOF MR angiography of the portal venous system: results of an intraindividual comparison.
    Reimer P; Marx C; Rummeny EJ; Müller M; Lentschig M; Balzer T; Dietl KH; Sulkowski U; Berns T; Shamsi K; Peters PE
    J Magn Reson Imaging; 1997; 7(6):945-9. PubMed ID: 9400835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasmall superparamagnetic iron oxide particles (AMI 227) as a blood pool contrast agent for MR angiography: experimental study in rabbits.
    Loubeyre P; Zhao S; Canet E; Abidi H; Benderbous S; Revel D
    J Magn Reson Imaging; 1997; 7(6):958-62. PubMed ID: 9400837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-pass evaluation of renal perfusion with TurboFLASH MR imaging and superparamagnetic iron oxide particles.
    Trillaud H; Grenier N; Degreze P; Louail C; Chambon C; Franconi JM
    J Magn Reson Imaging; 1993; 3(1):83-91. PubMed ID: 8428106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging.
    Briley-Saebo K; Bjørnerud A; Grant D; Ahlstrom H; Berg T; Kindberg GM
    Cell Tissue Res; 2004 Jun; 316(3):315-23. PubMed ID: 15103550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography.
    Bremer C; Allkemper T; Baermig J; Reimer P
    J Magn Reson Imaging; 1999 Sep; 10(3):461-7. PubMed ID: 10508309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
    Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
    AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of iron oxide particles (AMI 227) with a gadolinium complex (Gd-DOTA) in dynamic susceptibility contrast MR imagings (FLASH and EPI) for both phantom and rat brain at 1.5 Tesla.
    Loubeyre P; De Jaegere T; Bosmans H; Miao Y; Ni Y; Landuyt W; Marchal G
    J Magn Reson Imaging; 1999 Mar; 9(3):447-53. PubMed ID: 10194716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling.
    Yancy AD; Olzinski AR; Hu TC; Lenhard SC; Aravindhan K; Gruver SM; Jacobs PM; Willette RN; Jucker BM
    J Magn Reson Imaging; 2005 Apr; 21(4):432-42. PubMed ID: 15779033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.